Calif. Biotech Eyes $86M IPO To Fund Muscular Dystrophy Med
Venture capital-backed aTyr Pharma Inc. filed for an $86 million initial public offering Monday, coming a week after the muscular dystrophy treatment biotech landed venture capital investment from a group led...To view the full article, register now.
Already a subscriber? Click here to view full article